News headlines about Physicians Realty Trust (NYSE:DOC) have been trending positive this week, according to Accern Sentiment. The research firm identifies positive and negative press coverage by analyzing more than twenty million blog and news sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Physicians Realty Trust earned a media sentiment score of 0.34 on Accern’s scale. Accern also gave headlines about the real estate investment trust an impact score of 47.4221487004875 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the near term.

Here are some of the news headlines that may have impacted Accern’s rankings:

Shares of Physicians Realty Trust (NYSE DOC) opened at 18.67 on Tuesday. Physicians Realty Trust has a 12 month low of $17.12 and a 12 month high of $22.03. The company’s 50 day moving average price is $18.36 and its 200 day moving average price is $19.51. The stock has a market capitalization of $2.94 billion, a PE ratio of 79.79 and a beta of 0.55.

Physicians Realty Trust (NYSE:DOC) last released its earnings results on Thursday, August 3rd. The real estate investment trust reported $0.24 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.23 by $0.01. Physicians Realty Trust had a net margin of 11.51% and a return on equity of 1.75%. The business had revenue of $76.60 million during the quarter, compared to analysts’ expectations of $80.48 million. During the same quarter last year, the company earned $0.22 earnings per share. The firm’s revenue was up 43.9% on a year-over-year basis. Equities analysts anticipate that Physicians Realty Trust will post $0.27 earnings per share for the current fiscal year.

DOC has been the topic of several analyst reports. Cantor Fitzgerald reissued a “buy” rating and issued a $23.00 price target on shares of Physicians Realty Trust in a report on Friday, June 30th. BidaskClub raised Physicians Realty Trust from a “hold” rating to a “buy” rating in a report on Friday, June 23rd. Stifel Nicolaus decreased their target price on Physicians Realty Trust from $23.00 to $22.00 and set a “buy” rating for the company in a report on Wednesday, July 12th. Morgan Stanley raised Physicians Realty Trust from an “underweight” rating to an “equal weight” rating and set a $18.00 target price for the company in a report on Monday, July 24th. Finally, Jefferies Group LLC reaffirmed a “hold” rating and set a $21.00 target price on shares of Physicians Realty Trust in a report on Wednesday, June 14th. One research analyst has rated the stock with a sell rating, three have given a hold rating and eleven have issued a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and an average target price of $20.50.

COPYRIGHT VIOLATION WARNING: “Physicians Realty Trust (DOC) Receiving Positive News Coverage, Study Shows” was reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this news story on another domain, it was illegally copied and republished in violation of United States and international trademark & copyright law. The correct version of this news story can be read at https://www.thecerbatgem.com/2017/09/05/physicians-realty-trust-doc-receiving-positive-news-coverage-study-shows.html.

Physicians Realty Trust Company Profile

Physicians Realty Trust (the Trust) is a real estate investment trust. Physicians Realty L.P. is the operating partnership of the Trust. The Trust and its operating partnership are engaged in acquiring, developing, owning and managing healthcare properties that are leased to physicians, hospitals and healthcare delivery systems.

Insider Buying and Selling by Quarter for Physicians Realty Trust (NYSE:DOC)

Receive News & Stock Ratings for Physicians Realty Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Physicians Realty Trust and related stocks with our FREE daily email newsletter.